1. FDA warning of HBV reactivation during HCV antiviral therapy

   News item 15 October 2016 Pages: 1 - 1

2. FDA warns against homeopathic teething gels and tablets

   News item 15 October 2016 Pages: 2 - 2

3. Statins associated with muscle rupture

   News item 15 October 2016 Pages: 3 - 3

4. ADR reports from GPs in France not fully documented

   Clinical study 15 October 2016 Pages: 4 - 4

5. Adverse drug events in geriatric palliative care recipients

   Clinical study 15 October 2016 Pages: 5 - 5

6. Biologicals for IBD increase risk of infection, not malignancies

   Clinical study 15 October 2016 Pages: 6 - 6

7. Demand for genetic test for reducing risk of serious ADRs

   Clinical study 15 October 2016 Pages: 7 - 7

8. Drugs withdrawn from the US market analysed

   Clinical study 15 October 2016 Pages: 8 - 8

9. Ibuprofen associated with pulmonary arterial hypertension

   Clinical study 15 October 2016 Pages: 9 - 9

10. Naloxegol cost effective for opioid-induced constipation

    Clinical study 15 October 2016 Pages: 10 - 10

11. Oral bisphosphonates associated with Clostridium difficile infection

    Clinical study 15 October 2016 Pages: 11 - 11

12. Acetazolamide

    Case report 15 October 2016 Pages: 12 - 12

13. Aciclovir

    Case report 15 October 2016 Pages: 13 - 13

14. Adalimumab

    Case report 15 October 2016 Pages: 14 - 14

15. Adalimumab

    Case report 15 October 2016 Pages: 15 - 15

16. Adalimumab

    Case report 15 October 2016 Pages: 16 - 16

17. Ajmaline

    Case report 15 October 2016 Pages: 17 - 17

18. Aldesleukin

    Case report 15 October 2016 Pages: 18 - 18

19. Alemtuzumab

    Case report 15 October 2016 Pages: 19 - 19

20. Alemtuzumab

    Case report 15 October 2016 Pages: 20 - 20

21. Alemtuzumab

    Case report 15 October 2016 Pages: 21 - 21

22. Alemtuzumab/methylprednisolone

    Case report 15 October 2016 Pages: 22 - 22

23. Alprostadil/ginkgo biloba/sodium chloride

    Case report 15 October 2016 Pages: 23 - 23

24. Amiodarone/dasatinib/pantoprazole/valaciclovir

    Case report 15 October 2016 Pages: 24 - 24

25. Amiodarone/hydroxychloroquine/quinine

    Case report 15 October 2016 Pages: 25 - 25

26. Amiodarone/thiamazole

    Case report 15 October 2016 Pages: 26 - 26

27. Antibacterials/clozapine

    Case report 15 October 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 15 October 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 15 October 2016 Pages: 29 - 29

30. Antineoplastics

    Case report 15 October 2016 Pages: 30 - 30

31. Antineoplastics/dexamethasone

    Case report 15 October 2016 Pages: 31 - 31

32. Antituberculars/prednisone

    Case report 15 October 2016 Pages: 32 - 32

33. Apixaban/rivaroxaban/warfarin

    Case report 15 October 2016 Pages: 33 - 33

34. Aspirin

    Case report 15 October 2016 Pages: 34 - 34

35. Aspirin/clopidogrel/low molecular weight heparin

    Case report 15 October 2016 Pages: 35 - 35

36. Aspirin/ibuprofen interaction

    Case report 15 October 2016 Pages: 36 - 36

37. Avibactam/ceftazidime

    Case report 15 October 2016 Pages: 37 - 37

38. Azathioprine

    Case report 15 October 2016 Pages: 38 - 38

39. Azithromycin

    Case report 15 October 2016 Pages: 39 - 39

40. BCG

    Case report 15 October 2016 Pages: 40 - 40

41. BCG vaccine

    Case report 15 October 2016 Pages: 41 - 41

42. Bee venom

    Case report 15 October 2016 Pages: 42 - 42

43. Bendamustine/rituximab

    Case report 15 October 2016 Pages: 43 - 43

44. Betamethasone dipropionate/calcipotriol/betamethasone valerate/clobetasol

    Case report 15 October 2016 Pages: 44 - 44

45. Bevacizumab

    Case report 15 October 2016 Pages: 45 - 45

46. Bevacizumab/carboplatin/paclitaxel

    Case report 15 October 2016 Pages: 46 - 46

47. Bevacizumab/loxoprofen

    Case report 15 October 2016 Pages: 47 - 47

48. Calcitonin/zoledronic acid

    Case report 15 October 2016 Pages: 48 - 48

49. Capecitabine

    Case report 15 October 2016 Pages: 49 - 49

50. Carbamazepine

    Case report 15 October 2016 Pages: 50 - 50